BE Study of Once Daily PMR Compared to Twice Daily Cilostazol Tablets in Healthy Volunteers

NCT06167265 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Intermittent Claudication

Interventions

DRUG: Cilostazol Tablet 100 mg
DRUG: PMR Tablet 145 mg

Sponsor

Genovate Biotechnology Co., Ltd.,